Generation Bio Co

NASDAQ:GBIO   2:58:55 PM EDT
5.53
+0.20 (+3.66%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Generation Bio Co Stock, NASDAQ:GBIO

301 Binney Street, Cambridge, Massachusetts 02142-1071
United States of America
Phone: +1.617.655.7500
Number of Employees: 150

Description

Generation Bio Co. is a genetic medicine company focused on creating a new class of gene therapy to provide durable and redosable treatment for patients suffering from both rare and prevalent diseases. Its non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA, a novel cell-targeted lipid nanoparticle delivery system, or ctLNP, and an established, scalable capsid-free manufacturing process. The company was founded by Mark D. Angelino, Jason P. Rhodes, and Robert M. Kotin in 2016 and is headquartered in Cambridge, MA.